![Michelle Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Parker
Chief Executive Officer at
CLARITY PHARMACEUTICALS LTD
Net worth: 2 M $ as of 2026-07-30
Profile
Michelle Parker is currently the Chief Executive Officer & Director at Clarity Pharmaceuticals Ltd. She previously worked as the Head-International Clinical Research Operations at Novartis Australia Pty Ltd. Ms. Parker completed her undergraduate degree at The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 1,013,000 ( 0.27% ) | 2 M $ | 2026-07-30 |
Michelle Parker active positions
| Companies | Position | Start |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Chief Executive Officer | 2024-10-10 |
Former positions of Michelle Parker
| Companies | Position | End |
|---|---|---|
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Corporate Officer/Principal | - |
Training of Michelle Parker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Michelle Parker
